Research Group

Chirality of Drugs and Chiral Recognition

[RG #65] Chirality of Drugs and Chiral Recognition

November 1995 - August 1996

Organizer:

Israel Agranat (The Hebrew University of Jerusalem)

Read More
The notion of chirality has emerged as a major theme in drug design and discovery. Many of the new chiral drugs are being developed as single enantiomers. Chiral recognition is one of the most significant topics of contemporary stereochemical studies and is an essential component of pharmacological events.

 

Read Less
men

Dov Sagie

FELLOW
Weizmann Institute of Science
fellow

David Lambert

FELLOW
University of North Carolina at Chapel Hill

men

Israel Nelken

FELLOW
The Hebrew University of Jerusalem
Israel is a professor in the Department of Neurobiology and the Institute of Life Sciences at The Hebrew University of Jerusalem. His research interests are the auditory system, complex and natural sounds, and novelty detection.
poster

Oron Shagrir

FELLOW
The Hebrew University of Jerusalem
Oron Shagrir is a Professor of Philospohy and Cognitive Science at The Hebrew University of Jerusalem. His areas of research include the conceptual foundations of (mainly computational) cognitive and brain sciences, the history and philosophy of computing and computability, and philosophy of mind.
fellow

Daniella Talmon-Heller

FELLOW
Ben-Gurion University
Daniella is a professor in the Department of Middle East Studies at Ben-Gurion University of the Negev. Her research interests are the history of the Middle East in the Medieval period.